Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT02864381 · COMPLETED
Trial details
- NCT number
- NCT02864381
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-11-08
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.